Factors such as the rising prevalence of genetic and infectious diseases and surging investments and funds for PCR technologies propel the market growth. However, the high costs of PCR systems and the availability of alternative assays impede the PCR technologies market growth.

Increasing Adoption of PCR Techniques in Emerging Countries Creates Opportunities for the PCR Technologies Market.

In recent years, molecular methods such as PCR have evolved as diagnostic tools, enabling healthcare professionals to diagnose various infectious diseases accurately. It is also considered an indispensable research and diagnostic tool. PCR allows the early diagnosis of disease and hence plays an essential role in disease control. The technique provides reproducible results comparable to different laboratories and is accepted worldwide. PCR techniques are also being widely accepted and utilized in emerging countries. According to the World Health Organization Report on the Establishment of PCR Laboratory in Developing Countries 2016, WHO will provide technical assistance to establish PCR laboratories in all 11 WHO Southeast Asia countries. Depending on their need, these facilities have adopted different PCR technologies such as reverse transcriptase PCR (RT-PCR), multiplex PCR, real-time PCR, in-situ PCR, and dPCR. The application of PCR technologies is increasing in clinical microbiology, virology, parasitology, biotechnology, and allied fields due to this tool's simple, rapid, and highly specific screening. Thus, the PCR technologies market in developing countries is expected to experience lucrative opportunities during the forecast period.

The "Global PCR Technologies Market" is segmented based on technology, offerings, Applications, end Users, and geography.

Technology Overview

The PCR technologies market is segmented based on technology into real-time PCR, conventional PCR, reverse transcription, digital PCR (dPCR), multiplex RT-PCR, hot start PCR, and others. The real-time PCR segment held the largest market share in 2022 and is expected to register the highest CAGR.

Real-time PCR is a nuclear-based approach for identifying specific genetic material in any disease, including viruses. Originally, radioactive isotope markers were used to detect specific genetic elements, but later improvement resulted in applying specialized markers, most often fluorescent dyes, to replace isotopic labeling. Real-time PCR has become one of the most extensively used methods of gene quantification because of its dynamic range, remarkable sensitivity, ability to be very sequence-specific, lack of post-amplification processing, and ability to increase sample throughput. Real-time RT-PCR is one of the most extensively used laboratory methods for detecting the COVID-19 virus. While several nations have used real-time RT-PCR to diagnose diseases like Ebola and Zika, many nations still require help applying this technology to the COVID-19 virus and extending their national testing abilities.

End User Overview

Based on end users, the PCR technologies market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, and others. The hospitals and diagnostic centers segment held a larger market share in 2022. Moreover, the same segment is anticipated to register a higher CAGR of 8.7% during 2022-2030.

Hospitals and diagnostic centers contribute a significant market share to the PCR technologies market. Hospitals are the primary centers for patients seeking highly advanced treatment under the guidance of highly trained personnel. Various PCR technologies, such as dPCR and qPCR, offer high sensitivity and specificity, allowing early and accurate detection of pathogens, including bacteria, viruses, and fungi. Hospitals also offer advanced diagnosis and treatment options for patients to treat acute and chronic conditions, and the adoption of PCR techniques is much higher in hospitals and diagnostic centers as they provide healthcare facilities with specialized scientific equipment. Diagnostic laboratories are well-equipped with hi-tech equipment that enables easy workflow and management of various samples to be tested. For instance, Bio-Rad Laboratories, Inc., Fluidigm Corporation, Eppendorf, and Agilent Technologies, Inc. offer PCR devices to hospitals and diagnostic centers based on their capacity and requirements.

The global PCR technologies market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The North American regional market is expected to grow with a CAGR of 8.3% from 2022 to 2030. The increased demand for innovative products from bioanalytical instrument manufacturers and PCR companies, the presence of key market players, and extensive R&D conducted across various academic and research institutes are factors leading to market growth in the region. The Asia Pacific PCR technologies market holds the fastest CAGR. The factors contributing to the market progress in this region include the increasing foreign direct investments, the large availability of highly skilled, efficient workforces, and the streamlining of government policies, resulting in high investments in the biotechnology sector.

PCR technologies Market, by Region, 2022 (%)

Source: The Insight Partners Analysis

Atila Biosystems, Thermo Fisher Scientific, Inc.; Takara Bio Inc.; Standard BioTools Inc.; F.Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc; Agilent Technologies, BIOMERIEUX, QIAGEN, Promega Corporation; Becton, Dickinson and Company; Visby Medical, Inc.; and Ellume Limited are among the leading market players of PCR technologies market. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. Their widespread global presence allows them to serve many customers and subsequently increase their market share.

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876

Email Id: sales@premiummarketinsights.com